Emeritus Professor Ross Barnetson

Emeritus Professor
Dermatology, Central Clinical School

Telephone +61 2 9515 6861
Fax +61 2 9565 1048

Map

Biographical details

Ross Barnetson trained in Medicine at Edinburgh University between 1958 and 1964. For

three years during his medical training he served in the Territorial Army in the Airborne Division of the British Army. He also performed electives in Israel and the USA. After graduating in Edinburgh he joined the regular Army, and after training in Tropical Medicine was stationed in Cyprus for 2 years, where he worked at the British Military Hospital, Dhekelia and was a member of the Near East Parachute Force providing medical cover for the force. He was then stationed in West Malaysia and Singapore working in two Military Hospitals in Tropical Medicine. He retired from the army after 5 years. On leaving the army in 1970 he returned to Edinburgh and was appointed as a Registrar in Dermatology in the Professorial Unit at the Royal Infirmary. He became a member of the Royal College of Physicians (MRCP) by examination and continued as a Registrar in Dermatology for 3 years writing papers on a number of skin diseases such as dermatitis herpetiformis (a form of coeliac disease) and fungal infections. In 1974, he was appointed as a MRC Clinical Research Physician in Addis Ababa, Ethiopia working in the Armauer Hansen Research Institute. He performed a study of reversal reactions in leprosy and wrote his MD thesis on this subject. He wrote 10 papers on leprosy, and leishmaniasis, including one in Nature, one in Lancet and one in the British Medical Journal. In 1976, he returned to Edinburgh University as a lecturer in Dermatology, and continued as such till 1981: this included a six month period in immunology working with Prof Ivan Roitt FRS. As a lecturer he completed 30 papers on skin diseases mainly on allergy and atopic dermatitis. He was then appointed as a consultant and senior lecturer at the Royal Infirmary Edinburgh and Edinburgh University, where he continued until being appointed to the Chair of Dermatology at the University of Sydney in 1988. He was elected to be a Fellow of the Royal College of Physicians (London) and a Fellow of the Royal College of Physicians of Edinburgh. Between 1978 and 1987 he was a WHO consultant in leprosy paying several visits to India, Iran and Indonesia. During this time he wrote 30 further scientific papers on skin diseases and 15 chapters in books, both dermatological and immunological. One of these chapters describes for the first time, the concept of ATOPIC (ALLERGIC) MARCH (Barnetson and Gawkrodger). On taking up the Chair of Dermatology at the University of Sydney in 1988 which was the first Chair of Dermatology in Australia, he established laboratory research in Dermatology in Australia. As well as building up the clinical Department of Dermatology at Royal Prince Alfred Hospital, two large laboratories were commandeered and created into modern immunological laboratories under the supervision of Professor Gary Halliday, immunologist and world authority on skin cancer, and its prevention.

Selected grants

2009

  • Novel gene-targeted therapies for basil cell carcinoma; Halliday G, Kachigian L, Barnetson R; Cancer Institute New South Wales/Translational Program Grant.

2005

  • Monitoring Psoriasis treatments with protein microarrays; Dos Remedios C, Barnetson R; Psoriasis Australia Inc/Biennial Research Grant.
  • FACS Aria for the University of Sydney Flow Cytometry Facility; King N, Pollard J, Rasko J, Lovicu F, Bishop A, Bertolino P, Briscoe H, Gillies M, Madigan M, McAvoy J, Murphy C, Balcar V, Armour C, Hughes M, Reeve V, Christopherson R, Halliday G, Christie M, Pollock C, McCaughan G, Gorrell M, Dong Q, Abendroth A, Menzies S, Barnetson R, Byrne S, Hunt N, Hambly B, Cook D, Mason R, Day M, Black J; University of Sydney/Equipment Grant.

2004

  • The role of UVA in human skin carcinogenesis; Halliday G, Barnetson R, Jones A; Cancer Council New South Wales/Research Project Grants.
  • Determination of an action spectrum for ultraviolet radiation-induced immunosuppression in humans; Damian D, Barnetson R, Halliday G; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Determination of an action spectrum for ultraviolet radiation-induced immunosuppression of recall responses in humans; Damian D, Barnetson R; Cure Cancer Australia Foundation/Research Support.

2002

  • DNA damage induced by UVA and UVB in squamous cell carcinoma progression; Jones A, Halliday G, Barnetson R; National Health and Medical Research Council (NHMRC)/Project Grants.

2001

  • Solar-simulator for photocarcinogenesis and photobiological studies; Halliday G, Barnetson R; Clive & Vera Ramaciotti Foundation/Project Support.

2000

  • Sunscreen immune protection factor prediction of inhibition of anti-tumour immunity and carcinogenesis; Halliday G, Barnetson R; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Cho, E., Moloney, F., Cai, H., Au-Yeung, A., China, C., Scolyer, R., Yosu�?, B., Raftery, M., Deng, J., Morton, S., Damian, D., Barnetson, R., Halliday, G., et al (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet, 381(9880), 1835-1843. [More Information]
  • Khachigian, L., Cai, H., Moloney, F., Parish, C., Chong, B., Barnetson, R., Stocker, R., Halliday, G. (2012). Destroying c-Jun Messenger: New Insights into Biological Mechanisms of DNAzyme Function. Oncotarget, 3(6), 594-595. [More Information]
  • Cai, H., Santiago, F., Prado-Lourenco, L., Wang, B., Patrikakis, M., Davenport, M., Maghzal, G., Stocker, R., Parish, C., Chong, B., Moloney, F., Barnetson, R., Halliday, G., et al (2012). DNAzyme Targeting c-jun Suppresses Skin Cancer Growth. Science Translational Medicine, 4(139), 1-12. [More Information]
  • Bock, V., Lyons, G., Huang, X., Jones, A., McDonald, L., Scolyer, R., Moloney, F., Barnetson, R., Halliday, G. (2011). BRM and BRG1 subunits of the SWI�?�SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. British Journal of Dermatology, 164(6), 1221-1227. [More Information]
  • Damian, D., Patterson, C., Stapelberg, M., Park, J., Barnetson, R., Halliday, G. (2008). UV Radiation-Induced Immunosuppression Is Greater in Men and Prevented by Topical Nicotinamide. The Journal of Investigative Dermatology, 128(2), 447-454. [More Information]
  • Barnetson, R., Ooi, T., Zhuang, L., Halliday, G., Reid, C., Walker, P., Humphrey, S., Kleinig, M. (2006). [Nle(4)-D-Phe(7)]-alpha-Melanocyte-Stimulating Hormone Significantly Increased Pigmentation and Decreased UV Damage in Fair-Skinned Caucasian Volunteers. The Journal of Investigative Dermatology, 126(8), 1869-1878. [More Information]
  • Ibbotson, S., Jong, C., Lesar, A., Ferguson, J., Padgett, M., O’Dwyer, M., Barnetson, R., Ferguson, J. (2006). Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatology, Photoimmunology and Photomedicine, 22(2), 105-110.
  • Ooi, T., Barnetson, R., Zhuang, L., McKane, S., Lee, J., Slade, H., Halliday, G. (2006). Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial. British Journal of Dermatology, 154(1), 72-78. [More Information]
  • Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband. Photodermatology, Photoimmunology and Photomedicine, 22(4), 174-180. [More Information]
  • Pua, V., Scolyer, R., Barnetson, R. (2006). Pravastatin-induced lichenoid drug eruption. Australasian Journal of Dermatology, 47(1), 57-59. [More Information]
  • Pua, V., Barnetson, R. (2006). Recent developments in the treatment of adult atopic dermatitis. Australasian Journal of Dermatology, 47(2), 84-89. [More Information]
  • Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Spectral and dose dependence of ultraviolet radiation-induced immunosuppression. Frontiers in Bioscience, 11, 394-411. [More Information]
  • Zang, G., Luo, X., Sumithran, E., Pua, V., Barnetson, R., Halliday, G., Khachigian, L. (2006). Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene, 25, 7260-7266. [More Information]
  • Howes, R., Halliday, G., Barnetson, R., Friedmann, A., Damian, D. (2006). Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans. Journal of Dermatological Science, 44, 113-115. [More Information]
  • Damian, D., Barnetson, R., Thompson, J. (2006). Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. Journal of Cutaneous Medicine and Surgery, 10(1), 48-51.
  • Armour, K., Scolyer, R., Barnetson, R. (2005). Borderline lepromatous leprosy presenting as a single cutaneous plaque. Australasian Journal of Dermatology, 46(3), 181-183. [More Information]
  • Kuchel, J., Barnetson, R., Halliday, G. (2005). Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochemical and Photobiological Sciences, 4(8), 577-582. [More Information]
  • Patterson, C., Halliday, G., Barnetson, R., Damian, D. (2005). Effect of topical nicotinamide (vitamin B3) on ultraviolet radiation-induced immunosuppression in humans. Australasian Journal of Dermatology, 46(1), A10-A11.
  • Barnetson, R., Poon, T., Byrne, S., Halliday, G. (2005). Implication of immune protection factor on sunscreen development. Journal Of The American Academy Of Dermatology, 52(3 Supplement 2), AB9 (Ab# 156-02)-AB9.
  • Lowes, M., Turton, J., Krueger, J., Barnetson, R. (2005). Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series. B M C Dermatology, 5(9), 1-6. [More Information]
  • Poon, T., Barnetson, R., Halliday, G. (2005). Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. The Journal of Investigative Dermatology, 125(4), 840-846. [More Information]
  • Kuchel, J., Barnetson, R., Zhuang, L., Strickland, P., Pelley, R., Halliday, G. (2005). Tamarind inhibits solar-simulated ultraviolet radiation-induced suppression of recall responses in humans. Letters in Drug Design and Discovery, 2(2), 165-171.
  • Halliday, G., Agar, N., Barnetson, R., Ananthaswamy, H., Jones, A. (2005). UV-A Fingerprint Mutations in Human Skin Cancer. Photochemistry and Photobiology, 81(1), 3-8.
  • Barnetson, R., Satchell, A., Zhuang, L., Slade, H., Halliday, G. (2004). Imiquimod Induced Regression Of Clinically Diagnosed Superficial Basal Cell Carcinoma Is Associated With Early Infiltration By Cd4 T Cells And Dendritic Cells. Clinical and Experimental Dermatology, 29(6), 639-643.
  • Satchell, A., Barnetson, R., Halliday, G. (2004). Increased Fas Ligand Expression By T Cells And Tumour Cells In The Progression Of Actinic Keratosis To Squamous Cell Carcinoma. British Journal of Dermatology, 151(1), 42-49.
  • Agar, N., Halliday, G., Barnetson, R., Jones, A., Ananthaswamy, H., Wheeler, M. (2004). The Basal Layer In Human Squamous Tumors Harbors More Uva Than Uvb Fingerprint Mutations: A Role For Uva In Human Skin Carcinogenesis. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 101(14), 4954-4959.
  • Halliday, G., Byrne, S., Kuchel, J., Poon, T., Barnetson, R. (2004). The Suppression Of Immunity By Ultraviolet Radiation: Uva, Nitric Oxide And DNA Damage. Photochemical and Photobiological Sciences, 3(8), 736-740.
  • Friedmann, A., Halliday, G., Barnetson, R., Reeve, V., Walker, C., Patterson, C., Damian, D. (2004). The Topical Isoflavonoid Nv-07Alpha Reduces Solar-Simulated Uv-Induced Suppression Of Mantoux Reactions In Humans. Photochemistry and Photobiology, 80(3), 416-421.
  • Agar, N., Halliday, G., Barnetson, R., Jones, A. (2003). A novel technique for the examination of skin biopsies by laser capture microdissection. Journal Of Cutaneous Pathology, 30(4), 265-270.
  • Friedmann, P., Lee, M., Friedmann, A., Barnetson, R. (2003). Mechanisms in cutaneous drug hypersensitivity reactions. Clinical and Experimental Allergy, 33(7), 861-872.
  • Kuchel, J., Barnetson, R., Halliday, G. (2003). Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans. The Journal of Investigative Dermatology, 121(3), 587-593.
  • Poon, T., Kuchel, J., Badruddin, A., Halliday, G., Barnetson, R., Iwaki, H., Hatao, M. (2003). Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light. Photochemistry and Photobiology, 78(4), 331-336.
  • Poon, T., Barnetson, R., Halliday, G. (2003). Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. The Journal of Investigative Dermatology, 121(1), 184-190.
  • Barnetson, R., Eckstein, R., Robinson, B., Schnitzler, M. (2003). There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas wtih microsatellite instability. Genes Chromosomes and Cancer, 38(2), 149-156. [More Information]
  • Barnetson, R., Rogers, M. (2002). Childhood atopic eczema. BMJ: British Medical Journal, 324(7350), 1376-1379.
  • Kuanprasert, N., Herbert, O., Barnetson, R. (2002). Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine. Australasian Journal of Dermatology, 42(1), 125-127.
  • Halliday, G., Poon, T., Damian, D., Barnetson, R. (2002). Immune protection factor of sunscreens in humans is dependent on protection from UVA and cannot be predicted from the sun protection factor. Journal of Photoscience, 9, 236-239.
  • Berhane, T., Halliday, G., Cooke, B., Barnetson, R. (2002). Inflammation is associated with progression of actinic keratoses to squamous cell carcinoomas in humans. British Journal of Dermatology, 146(5), 810-815.
  • Hiramanek, N., Barnetson, R., Kossard, S. (2002). Multicentre reticulohistiocytosis presenting with a rash and arthralgia. Australasian Journal of Dermatology, 43(2), 136-139.
  • Kuchel, J., Barakate, M., Delbridge, L., Agarwal, G., Beattie, J., Barnetson, R. (2002). Short-term resolution of psoriasis after total thyroidectomy for euthyroid multinodular goitre. Australasian Journal of Dermatology, 43(3), 214-217.
  • Poon, T., Barnetson, R. (2002). The importance of using broad spectrum SPF 30+ in tropical and subtropical climates. Photodermatology, Photoimmunology and Photomedicine, 18(4), 175-178.
  • Satchell, A., Saurajen, A., Bell, C., Barnetson, R. (2002). Treatment of dandruff with 5% tea tree oil shampoo. Journal Of The American Academy Of Dermatology, 47(6), 852-855.
  • Satchell, A., Saurajen, A., Bell, C., Barnetson, R. (2002). Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: A randomized, placebo-controlled, blinded study. Australasian Journal of Dermatology, 43(3), 175-178.
  • Barnetson, R., Halliday, G., Damian,, D. (2001). Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses. Australasian Journal of Dermatology, 42, 161-167.
  • Barnetson, R., Rose, B., Thompson, J., Damian,, D., Bonenkamp, J. (2001). Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australasian Journal of Dermatology, 42, 106-109.
  • Wong, D., Bishop, A., Lowes, M., Cooke, B., Barnetson, R., Halliday, G. (2000). Cytokine profiles in spontaneously regressing basal cell carcinomas. British Journal of Dermatology, 143(1), 91-98.

Conferences

  • Barnetson, R. (2006). Melanotan, Nle4, D-Phe7 -alpha-MSH, significantly increased pigmentation and decreased UV damage in fair-skinned white volunteers. 64th Annual Meeting of the American Academy of Dermatology, United States: Mosby Inc.
  • Barnetson, R., Poon, T., Byrne, S., Halliday, G. (2005). Implication of immune protection factor on sunscreen development. 63rd Annual Meeting of the American Academy of Dermatology, United States: Mosby Inc.

Patents

  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).

2013

  • Cho, E., Moloney, F., Cai, H., Au-Yeung, A., China, C., Scolyer, R., Yosu�?, B., Raftery, M., Deng, J., Morton, S., Damian, D., Barnetson, R., Halliday, G., et al (2013). Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER). The Lancet, 381(9880), 1835-1843. [More Information]

2012

  • Khachigian, L., Cai, H., Moloney, F., Parish, C., Chong, B., Barnetson, R., Stocker, R., Halliday, G. (2012). Destroying c-Jun Messenger: New Insights into Biological Mechanisms of DNAzyme Function. Oncotarget, 3(6), 594-595. [More Information]
  • Cai, H., Santiago, F., Prado-Lourenco, L., Wang, B., Patrikakis, M., Davenport, M., Maghzal, G., Stocker, R., Parish, C., Chong, B., Moloney, F., Barnetson, R., Halliday, G., et al (2012). DNAzyme Targeting c-jun Suppresses Skin Cancer Growth. Science Translational Medicine, 4(139), 1-12. [More Information]

2011

  • Bock, V., Lyons, G., Huang, X., Jones, A., McDonald, L., Scolyer, R., Moloney, F., Barnetson, R., Halliday, G. (2011). BRM and BRG1 subunits of the SWI�?�SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours. British Journal of Dermatology, 164(6), 1221-1227. [More Information]

2008

  • Thompson, J., Armstrong, B., Barbour, A., Barnetson, R., Beanland, H., Beer, T., Brookshank, M., Burmeister, B., Butow, P., Clark, K., Conway, R., Damian, D., Frommer, M., Kefford, R., Lee, S., Mason, R., Mann, G., McCarthy, W., Menzies, S., Olver, I., Quinn, M., Saw, R., Shaw, H., Stretch, J., Barraclough, B., Holt, P., Reeve, T., et al (2008).
  • Damian, D., Patterson, C., Stapelberg, M., Park, J., Barnetson, R., Halliday, G. (2008). UV Radiation-Induced Immunosuppression Is Greater in Men and Prevented by Topical Nicotinamide. The Journal of Investigative Dermatology, 128(2), 447-454. [More Information]

2006

  • Barnetson, R., Ooi, T., Zhuang, L., Halliday, G., Reid, C., Walker, P., Humphrey, S., Kleinig, M. (2006). [Nle(4)-D-Phe(7)]-alpha-Melanocyte-Stimulating Hormone Significantly Increased Pigmentation and Decreased UV Damage in Fair-Skinned Caucasian Volunteers. The Journal of Investigative Dermatology, 126(8), 1869-1878. [More Information]
  • Ibbotson, S., Jong, C., Lesar, A., Ferguson, J., Padgett, M., O’Dwyer, M., Barnetson, R., Ferguson, J. (2006). Characteristics of 5-aminolaevulinic acid-induced protoporphyrin IX fluorescence in human skin in vivo. Photodermatology, Photoimmunology and Photomedicine, 22(2), 105-110.
  • Ooi, T., Barnetson, R., Zhuang, L., McKane, S., Lee, J., Slade, H., Halliday, G. (2006). Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial. British Journal of Dermatology, 154(1), 72-78. [More Information]
  • Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Melanin differentially protects from the initiation and progression of threshold UV-induced erythema depending on UV waveband. Photodermatology, Photoimmunology and Photomedicine, 22(4), 174-180. [More Information]
  • Barnetson, R. (2006). Melanotan, Nle4, D-Phe7 -alpha-MSH, significantly increased pigmentation and decreased UV damage in fair-skinned white volunteers. 64th Annual Meeting of the American Academy of Dermatology, United States: Mosby Inc.
  • Pua, V., Scolyer, R., Barnetson, R. (2006). Pravastatin-induced lichenoid drug eruption. Australasian Journal of Dermatology, 47(1), 57-59. [More Information]
  • Pua, V., Barnetson, R. (2006). Recent developments in the treatment of adult atopic dermatitis. Australasian Journal of Dermatology, 47(2), 84-89. [More Information]
  • Phan, T., Halliday, G., Barnetson, R., Damian, D. (2006). Spectral and dose dependence of ultraviolet radiation-induced immunosuppression. Frontiers in Bioscience, 11, 394-411. [More Information]
  • Zang, G., Luo, X., Sumithran, E., Pua, V., Barnetson, R., Halliday, G., Khachigian, L. (2006). Squamous cell carcinoma growth in mice and in culture is regulated by c-Jun and its control of matrix metalloproteinase-2 and -9 expression. Oncogene, 25, 7260-7266. [More Information]
  • Howes, R., Halliday, G., Barnetson, R., Friedmann, A., Damian, D. (2006). Topical capsaicin reduces ultraviolet radiation-induced suppression of Mantoux reactions in humans. Journal of Dermatological Science, 44, 113-115. [More Information]
  • Damian, D., Barnetson, R., Thompson, J. (2006). Treatment of refractory chromomycosis by isolated limb infusion with melphalan and actinomycin D. Journal of Cutaneous Medicine and Surgery, 10(1), 48-51.

2005

  • Armour, K., Scolyer, R., Barnetson, R. (2005). Borderline lepromatous leprosy presenting as a single cutaneous plaque. Australasian Journal of Dermatology, 46(3), 181-183. [More Information]
  • Kuchel, J., Barnetson, R., Halliday, G. (2005). Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochemical and Photobiological Sciences, 4(8), 577-582. [More Information]
  • Patterson, C., Halliday, G., Barnetson, R., Damian, D. (2005). Effect of topical nicotinamide (vitamin B3) on ultraviolet radiation-induced immunosuppression in humans. Australasian Journal of Dermatology, 46(1), A10-A11.
  • Barnetson, R., Poon, T., Byrne, S., Halliday, G. (2005). Implication of immune protection factor on sunscreen development. 63rd Annual Meeting of the American Academy of Dermatology, United States: Mosby Inc.
  • Barnetson, R., Poon, T., Byrne, S., Halliday, G. (2005). Implication of immune protection factor on sunscreen development. Journal Of The American Academy Of Dermatology, 52(3 Supplement 2), AB9 (Ab# 156-02)-AB9.
  • Lowes, M., Turton, J., Krueger, J., Barnetson, R. (2005). Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series. B M C Dermatology, 5(9), 1-6. [More Information]
  • Poon, T., Barnetson, R., Halliday, G. (2005). Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. The Journal of Investigative Dermatology, 125(4), 840-846. [More Information]
  • Kuchel, J., Barnetson, R., Zhuang, L., Strickland, P., Pelley, R., Halliday, G. (2005). Tamarind inhibits solar-simulated ultraviolet radiation-induced suppression of recall responses in humans. Letters in Drug Design and Discovery, 2(2), 165-171.
  • Halliday, G., Agar, N., Barnetson, R., Ananthaswamy, H., Jones, A. (2005). UV-A Fingerprint Mutations in Human Skin Cancer. Photochemistry and Photobiology, 81(1), 3-8.

2004

  • Barnetson, R., Satchell, A., Zhuang, L., Slade, H., Halliday, G. (2004). Imiquimod Induced Regression Of Clinically Diagnosed Superficial Basal Cell Carcinoma Is Associated With Early Infiltration By Cd4 T Cells And Dendritic Cells. Clinical and Experimental Dermatology, 29(6), 639-643.
  • Satchell, A., Barnetson, R., Halliday, G. (2004). Increased Fas Ligand Expression By T Cells And Tumour Cells In The Progression Of Actinic Keratosis To Squamous Cell Carcinoma. British Journal of Dermatology, 151(1), 42-49.
  • Agar, N., Halliday, G., Barnetson, R., Jones, A., Ananthaswamy, H., Wheeler, M. (2004). The Basal Layer In Human Squamous Tumors Harbors More Uva Than Uvb Fingerprint Mutations: A Role For Uva In Human Skin Carcinogenesis. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 101(14), 4954-4959.
  • Halliday, G., Byrne, S., Kuchel, J., Poon, T., Barnetson, R. (2004). The Suppression Of Immunity By Ultraviolet Radiation: Uva, Nitric Oxide And DNA Damage. Photochemical and Photobiological Sciences, 3(8), 736-740.
  • Friedmann, A., Halliday, G., Barnetson, R., Reeve, V., Walker, C., Patterson, C., Damian, D. (2004). The Topical Isoflavonoid Nv-07Alpha Reduces Solar-Simulated Uv-Induced Suppression Of Mantoux Reactions In Humans. Photochemistry and Photobiology, 80(3), 416-421.

2003

  • Agar, N., Halliday, G., Barnetson, R., Jones, A. (2003). A novel technique for the examination of skin biopsies by laser capture microdissection. Journal Of Cutaneous Pathology, 30(4), 265-270.
  • Friedmann, P., Lee, M., Friedmann, A., Barnetson, R. (2003). Mechanisms in cutaneous drug hypersensitivity reactions. Clinical and Experimental Allergy, 33(7), 861-872.
  • Kuchel, J., Barnetson, R., Halliday, G. (2003). Nitric oxide appears to be a mediator of solar-simulated ultraviolet radiation-induced immunosuppression in humans. The Journal of Investigative Dermatology, 121(3), 587-593.
  • Poon, T., Kuchel, J., Badruddin, A., Halliday, G., Barnetson, R., Iwaki, H., Hatao, M. (2003). Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light. Photochemistry and Photobiology, 78(4), 331-336.
  • Poon, T., Barnetson, R., Halliday, G. (2003). Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. The Journal of Investigative Dermatology, 121(1), 184-190.
  • Barnetson, R., Eckstein, R., Robinson, B., Schnitzler, M. (2003). There is no increase in frequency of somatic mutations in metastases compared with primary colorectal carcinomas wtih microsatellite instability. Genes Chromosomes and Cancer, 38(2), 149-156. [More Information]

2002

  • Barnetson, R., Rogers, M. (2002). Childhood atopic eczema. BMJ: British Medical Journal, 324(7350), 1376-1379.
  • Kuanprasert, N., Herbert, O., Barnetson, R. (2002). Clinical improvement and significant reduction of total serum IgE in patients suffering from severe atopic dermatitis treated with oral azathioprine. Australasian Journal of Dermatology, 42(1), 125-127.
  • Halliday, G., Poon, T., Damian, D., Barnetson, R. (2002). Immune protection factor of sunscreens in humans is dependent on protection from UVA and cannot be predicted from the sun protection factor. Journal of Photoscience, 9, 236-239.
  • Berhane, T., Halliday, G., Cooke, B., Barnetson, R. (2002). Inflammation is associated with progression of actinic keratoses to squamous cell carcinoomas in humans. British Journal of Dermatology, 146(5), 810-815.
  • Hiramanek, N., Barnetson, R., Kossard, S. (2002). Multicentre reticulohistiocytosis presenting with a rash and arthralgia. Australasian Journal of Dermatology, 43(2), 136-139.
  • Kuchel, J., Barakate, M., Delbridge, L., Agarwal, G., Beattie, J., Barnetson, R. (2002). Short-term resolution of psoriasis after total thyroidectomy for euthyroid multinodular goitre. Australasian Journal of Dermatology, 43(3), 214-217.
  • Poon, T., Barnetson, R. (2002). The importance of using broad spectrum SPF 30+ in tropical and subtropical climates. Photodermatology, Photoimmunology and Photomedicine, 18(4), 175-178.
  • Satchell, A., Saurajen, A., Bell, C., Barnetson, R. (2002). Treatment of dandruff with 5% tea tree oil shampoo. Journal Of The American Academy Of Dermatology, 47(6), 852-855.
  • Satchell, A., Saurajen, A., Bell, C., Barnetson, R. (2002). Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: A randomized, placebo-controlled, blinded study. Australasian Journal of Dermatology, 43(3), 175-178.

2001

  • Barnetson, R., Halliday, G., Damian,, D. (2001). Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses. Australasian Journal of Dermatology, 42, 161-167.
  • Barnetson, R., Rose, B., Thompson, J., Damian,, D., Bonenkamp, J. (2001). Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D. Australasian Journal of Dermatology, 42, 106-109.

2000

  • Wong, D., Bishop, A., Lowes, M., Cooke, B., Barnetson, R., Halliday, G. (2000). Cytokine profiles in spontaneously regressing basal cell carcinomas. British Journal of Dermatology, 143(1), 91-98.

To update your profile click here. For support on your academic profile contact .